Kilitch Drug (India) secures $9.1m tender in Ethiopia

In a significant development, Kilitch Drug (India) Limited, a renowned multinational pharmaceutical company, announced through its subsidiary, Kilitch Estro Biotech PLC, the acquisition of a substantial tender valued at approximately USD 9.13 million from the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia. This achievement not only highlights the company’s capacity to secure large-scale contracts but also underscores its growing influence and reliability in the international pharmaceutical landscape.

The tender awarded to Kilitch Estro Biotech PLC involves the supply of pharmaceuticals, with the contract size reaching USD 9.13 million. Set to be executed within a six-month period from the order receipt, this win demonstrates Kilitch Drug (India) Limited’s operational efficiency and its subsidiary’s ability to fulfill significant orders promptly and effectively. This contract marks a pivotal moment for Kilitch Drug, reinforcing its status as a key player in the global pharmaceutical sector.

The procurement of this tender by Kilitch Drug’s subsidiary is not just a standalone achievement but a testament to the company’s strategic positioning and quality assurance that have paved the way for potential recurring orders from the Ethiopian Pharmaceutical Supply Service. “It is a significant achievement for the company,” stated Mr. Mukund Mehta, Managing Director of Kilitch Drug (India) Limited. He further emphasized the importance of this milestone, indicating the opening of new avenues for the company in securing government contracts and solidifying its presence in the Ethiopian market.

This contract win is a clear indicator of Kilitch Drug (India) Limited’s robust supply chain and high-quality product offerings. It showcases the company’s ability to meet substantial market demands and its readiness to expand its market reach, particularly in government sectors across international borders. The anticipated recurring orders from the Ethiopian Pharmaceutical Supply Service suggest a long-term engagement, enhancing Kilitch Drug’s market footprint and contributing to its growth trajectory in the African pharmaceutical market.